ETOPOSID EBEWE 20MG-ML VIAL 5ML

Product Description

Etoposid Ebewe 20mg/ml Vials contain Etoposide, an antineoplastic agent used in the treatment of various cancers.

It belongs to the class of topoisomerase inhibitors, working by interfering with DNA synthesis and replication in cancer cells.

This medication is an integral part of specific chemotherapy regimens and is administered under strict medical supervision.

Given its specialized nature, detailed clinical information is typically obtained from medical professionals and official pharmaceutical sources, rather than general e-commerce platforms.

Benefits of Use

• Provides targeted action against certain types of rapidly dividing cancer cells.
• Effective as a component in multi-agent chemotherapy protocols for specific malignancies.
• Contributes to the reduction of tumor growth and disease management for appropriate cancer indications.

How To Use

Etoposid Ebewe 20mg/ml Vials are strictly for intravenous administration and must be handled and administered by a qualified healthcare professional.

Adherence to medical guidelines, patient-specific protocols, and aseptic techniques is essential.

1. The concentrate must be diluted with an appropriate intravenous solution (e.g., Sodium Chloride 0.9% or Glucose 5%) prior to infusion.
2. Administer slowly by intravenous infusion, typically over a period of 30 to 60 minutes, to minimize the risk of hypotension.
3. The exact dosage, treatment schedule, and duration are precisely determined by the prescribing physician based on the specific cancer type, patient's overall health, and other concurrent therapies.
4. Patients receiving Etoposide Ebewe will require regular monitoring of blood counts, liver function, and kidney function throughout the course of treatment.

Caution & Warnings

• This medication should only be administered in a clinical setting under the direct supervision of an oncologist or a physician experienced in chemotherapy.
• Severe myelosuppression (bone marrow suppression), leading to neutropenia, thrombocytopenia, and anemia, is a significant and dose-limiting toxicity. Close hematological monitoring is crucial.
• May cause severe hypersensitivity reactions, including anaphylaxis, which can be life-threatening. Emergency equipment and medications should be readily available.
• Contact with the solution should be avoided. Healthcare professionals should wear gloves and protective clothing during preparation and administration to prevent skin and mucous membrane exposure.
• Not recommended for use in pregnant or breastfeeding women due to its genotoxic and teratogenic potential. Effective contraception is required for patients of reproductive potential during and after treatment.
• Inform your healthcare provider about all current medications, including prescription drugs, over-the-counter medicines, herbal supplements, and dietary products, to prevent potential drug interactions.

Ingredients

• Active Ingredient: Etoposide 20 mg/ml
• Excipients: For a complete list of excipients, please refer to the product's official package leaflet or Summary of Product Characteristics (SPC).

Product Details

• Form: Solution for Injection
• Strength: 20 mg/ml
• Package Size: 5ml Vial
• Manufacturer: Ebewe Pharma Ges.m.b.H. (Sandoz)